Online citations, reference lists, and bibliographies.
← Back to Search

Idiopathic Thrombocytopenic Purpura: A Practice Guideline Developed By Explicit Methods For The American Society Of Hematology.

J. George, S. Woolf, G. Raskob, J. Wasser, L. Aledort, P. Ballem, V. Blanchette, J. Bussel, D. Cines, J. Kelton, A. Lichtin, R. Mcmillan, J. Okerbloom, D. H. Regan, I. Warrier
Published 1996 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
DIOPATHIC thrombocytopenic purpura (ITP, also I known as primary immune thrombocytopenic purpura) is a hematologic disorder for which appropriate diagnostic and treatment strategies are uncertain. In 1994, the American Society of Hematology (ASH) established a panel to produce explicitly developed practice guidelines for the diagnosis and management of ITP. “Explicitly developed,” evidencebased practice guidelines, which are being issued increasingly by medical specialty societies, combine a critical appraisal of scientific evidence with practice recommendations that state clearly to what extent the guidelines are based either on published scientific evidence or opinion (eg, clinical experience).I4 More details about the clinical practice guideline movement are provided elsewhere.’.’ This report begins with a brief summary of the panel’s recommendations, followed by a more detailed analysis of its methodology, the findings of the comprehensive literature review, and a full presentation of the recommendations. The report concludes with recommendations for future research. As explained later, the recommendations are based on the panel’s opinion, derived from a systematic scoring methodology. (Only recommendations receiving scores of 1 .O to 3.0 or 7.0 to 9.0, as defined later in the text, are cited in this summary.)
This paper references
10.1001/ARCHINTE.1951.03810120002001
Idiopathic thrombocytopenia; review of eighty-nine cases with particular reference to the differentiation and treatment of acute (self-limited and chronic types).
E. O. Hirsch (1951)
10.1001/JAMA.1959.03010320001001
Treatment of idiopathic thrombocytopenic purpura.
A. E. Carpenter (1959)
The treatment of idiopathic thrombocytopenic purpura.
Macpherson Ai (1959)
10.7326/0003-4819-53-5-861
IDIOPATHIC AND SECONDARY THROMBOCYTOPENIC PURPURA: CLINICAL STUDY AND EVALUATION OF 381 CASES OVER A PERIOD OF 28 YEARS
C. Doan (1960)
10.1097/00000441-196109000-00004
RESULTS OF TREATMENT IN 71 PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA
M. C. Meyers (1961)
10.1016/S0022-3476(66)80218-4
Idiopathic thrombocytopenic purpura in childhood.
J. Lusher (1966)
10.1016/S0022-3476(66)80205-6
Fresh plasma transfusions in the treatment of acute thrombocytopenic purpura.
C. W. Reiquam (1966)
10.1001/ARCHSURG.1966.01320220040006
Splenectomy for idiopathic thrombocytopenic purpura.
G. Block (1966)
10.1056/NEJM196609222751202
Refractory idiopathic thrombocytopenic purpura treated with azathioprine.
B. Bouroncle (1966)
10.1056/NEJM196606022742207
Idiopathic thrombocytopenic purpura.
M. Baldini (1966)
10.1001/JAMA.1967.03130170059006
Azathioprine in refractory idiopathic thrombocytopenic purpura.
L. Sussman (1967)
Idiopathic thrombocytopenic purpura in childhood.
S. I. Choi (1967)
10.1001/ARCHSURG.1967.01330150020004
Splenectomy for chronic idiopathic thrombocytopenic purpura.
R. Wilde (1967)
10.7326/0003-4819-66-2-301
Palpable spleens in college freshmen.
O. Mcintyre (1967)
10.1172/JCI105740
Metabolic effects of human growth hormone in corticosteroid-treated children.
H. Morris (1968)
10.1002/BJS.1800550608
Splenectomy in idiopathic thrombocytopenic purpura
D. Charlesworth (1968)
10.1001/JAMA.1969.03150240069006
Treatment of refractory idiopathic thrombocytopenic purpura.
B. Bouroncle (1969)
10.1002/BJS.1800561118
Splenectomy in the treatment of idiopathic thrombocytopenic purpura
P. Brooks (1969)
10.1016/0022-3468(70)90272-1
The role of splenectomy in neonatal idiopathic thrombocytopenic purpura.
J. Grosfeld (1970)
10.1111/j.1651-2227.1970.tb15536.x
THE USE OF AZATHIOPRINE IN REFRACTORY IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDREN
M. Hilgartner (1970)
10.1001/JAMA.1971.03180160045011
"Refractory" thrombocytopenic purpura treated successfully with cyclophosphamide.
R. Laros (1971)
10.1111/j.1440-1754.1972.tb01844.x
IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDREN: RESULTS OF STEROID THERAPY AND SPLENECTOMY
E. S. Benham (1972)
10.1016/S0022-3476(73)80308-7
Idiopathic thrombocytopenic purpura: an epidemiologic study.
A. Lammi (1973)
Intermittent cyclophosphamide treatment of autoimmune thombocytopenia.
B. Weinerman (1974)
10.1056/NEJM197408222910802
Vincristine therapy of idiopathic and secondary thrombocytopenias.
Y. Ahn (1974)
V therapy of idiopathic and secondary thrombocytopenias
YS Ahn (1974)
10.1016/S0022-3476(75)80061-8
Idiopathic thrombocytopenic purpura in children.
S. M. Simons (1975)
10.1016/0002-9610(75)90197-X
Correlation between response to corticosteroids and splenectomy for adult idiopathic thrombocytopenic purpura.
M. Brennan (1975)
10.1002/AJH.2830010111
Treatment of refractory thrombocytopenic purpura with cyclophosphamide
M. Verlin (1976)
Responses to vincristine in refractory idiopathic thrombocytopenic purpura
IE Burton (1976)
10.1055/S-0028-1086135
Management of idiopathic thrombocytopenic purpura in the adult.
J. Lacey (1977)
Thrombocytopenia: mechanisms and management of defects in platelet production.
Slichter Sj (1978)
Accessory splenectomy in management of recurrent idiopathic thrombocytopenic purpura.
C. Verheyden (1978)
10.1056/NEJM197805182982001
The treatment of idiopathic thrombocytopenia with vinblastine-loaded platelets.
Y. Ahn (1978)
10.1016/S0022-3468(78)80394-7
Emergency splenectomy for idiopathic thrombocytopenic purpura in children.
J. T. Zerella (1978)
10.1002/AJH.2830070111
Acute idiopathic thrombocytopenic purpura in children
N. Mcwilliams (1979)
10.1136/pgmj.56.660.711
Low-dose vincristine in the treatment of corticosteroid-refractory idiopathic thrombocytopenic purpura (ITP) in non-splenectomized patients.
F. Cervantes (1980)
10.1016/0002-9343(80)90419-2
Fate of therapy failures in adult idiopathic thrombocytopenic purpura.
V. Picozzi (1980)
10.1001/ARCHINTE.1980.00330170052024
Chronic immunologic thrombocytopenic purpura: results of cyclophosphamide therapy before splenectomy.
T. Srichaijul (1980)
10.1016/0002-9378(80)90677-8
Fetal platelet counts in the obstetric management of immunologic thrombocytopenic purpura.
J. Scott (1980)
10.1016/0002-9343(80)90016-9
Adult idiopathic thrombocytopenic purpura. Clinical findings and response to therapy.
S. M. DiFino (1980)
10.1182/BLOOD.V57.3.431.BLOODJOURNAL573431
The reversible binding of vinblastine to platelets: implications for therapy.
J. Kelton (1981)
10.1056/NEJM198110153051607
Platelet Counts in Infants of Women with Autoimmune Thrombocytopenia
M. Karpatkin (1981)
10.1046/j.1537-2995.1981.21381201800.x
One‐Year Follow‐Up of Plasma Exchange Therapy in 14 Patients with Idiopathic Thrombocytopenic Purpura
V. Marder (1981)
Intracranial hemorrhage in children with idiopathic thrombocytopenic purpura.
S. Woerner (1981)
The newborn and maternal idiopathic thrombocytopenic purpura.
Woon Ky (1981)
Table 1 . Lack of relation between maternal and neonatal platelet counts
A Aviles (1981)
10.1016/0020-7292(82)90041-8
The obstetrical management of patients with immunologic thrombocytopenic purpura
I. Kessler (1982)
10.1002/MPO.2950100110
Chronic idiopathic thrombocytopenic purpura (ITP:) development of acute non-lymphocytic leukemia subsequent to treatment with cyclophosphamide.
J. R. Krause (1982)
Accessory splenectomy for idiopathic thrombocytopenic purpura.
D. Wallace (1982)
10.1093/OXFORDJOURNALS.QJMED.A067718
Acute myelogenous leukaemia following cytotoxic therapy: five cases and a review.
A. Smith (1982)
10.1016/0002-9378(82)90252-6
The prenatal prediction of thrombocytopenia in infants of mothers with clinically diagnosed immune thrombocytopenia.
J. Kelton (1982)
10.1097/00006254-198210000-00006
Immune Thrombocytopenic Purpura and Pregnancy
D. Cines (1982)
Chronic idiopathic thrombocytopenic purpura: effective preoperative preparation and long-term results of splenectomy.
Gruenberg Jc (1982)
10.1016/0002-9378(83)90843-8
Antiplatelet antibodies and platelet counts in pregnancies complicated by autoimmune thrombocytopenic purpura.
J. Scott (1983)
10.1159/000206927
High-dose gammaglobulin therapy for idiopathic thrombocytopenic purpura in adults.
Y. Kurata (1983)
10.1056/NEJM198306093082306
Danazol for the treatment of idiopathic thrombocytopenic purpura.
Y. Ahn (1983)
10.1016/0002-9378(83)90990-0
Thrombocytopenia and infant platelet count.
J. Pizzuto (1983)
10.1111/j.1600-0897.1983.tb00242.x
Studies by Enzyme‐Linked Immunosorbent Assay (ELISA) of Antiplatelet Antibody and Transient Neonatal Thrombocytopenic Purpura *
N. Rote (1983)
10.1016/S0022-3476(83)80608-8
Intravenous use of gammaglobulin in the treatment of chronic immune thrombocytopenic purpura as a means to defer splenectomy.
J. Bussel (1983)
10.1016/0002-9378(83)90481-7
The effect of maternal steroid administration on fetal platelet count in immunologic thrombocytopenic purpura. Management of pregnancy and mode of delivery.
T. E. Logaridis (1983)
10.1111/J.1600-0609.1983.TB02134.X
Treatment of adult autoimmune thrombocytopenic purpura with high-dose intravenous plasmin-cleaved gammaglobulins.
P. Solal-Celigny (1983)
10.7326/0003-4819-100-2-192
Slow infusion of vinca alkaloids in the treatment of idiopathic thrombocytopenic purpura.
Y. Ahn (1984)
Splenectomy for chronic idiopathic thrombocytopenic purpura.
B. Salky (1984)
10.1055/S-0038-1661053
A cooperative clinical trial of high-dose immunoglobulin therapy in 177 cases of idiopathic thrombocytopenic purpura.
H. Uchino (1984)
10.1097/00043426-198406020-00008
Steroid treatment of idiopathic thrombocytopenic purpura in children. Preliminary results of a randomized cooperative study.
J. Sartorius (1984)
10.1182/BLOOD.V64.6.1179.BLOODJOURNAL6461179
Therapeutic experience on 934 adults with idiopathic thrombocytopenic purpura: Multicentric Trial of the Cooperative Latin American group on Hemostasis and Thrombosis
J. Pizzuto (1984)
10.1016/0002-9378(84)90532-5
Route of delivery for patients with immune thrombocytopenic purpura.
R. Laros (1984)
10.1016/S0022-3476(84)80434-5
Corticosteroid therapy in thrombocytopenic infants of women with autoimmune thrombocytopenia.
M. Karpatkin (1984)
10.1046/j.1537-2995.1984.24585017826.x
Intensive plasma exchange therapy in ten patients with idiopathic thrombocytopenic purpura
V. Blanchette (1984)
10.1016/0002-9343(84)90340-1
Intravenous gamma globulin in the treatment of chronic idiopathic thrombocytopenic purpura in adults.
A. Oral (1984)
10.1097/00000658-198407000-00006
Splenectomy for Hematologic Disease: The UCLA Experience with 306 Patients
G. Musser (1984)
10.1136/adc.59.4.316
Idiopathic thrombocytopenia, initial illness and long term follow up.
R. W. Walker (1984)
10.1093/AJCP/81.3.317
Pseudoleukocytosis due to EDTA-induced platelet clumping.
Richard d. Savage (1984)
10.1016/0002-9343(84)90339-5
Intravenous immunoglobulin administration in the treatment of severe chronic immune thrombocytopenic purpura.
R. N. Carroll (1984)
10.1016/0002-9378(84)90214-X
Pregnancy and immune thrombocytopenic purpura.
C. J. Wahbeh (1984)
10.1016/S0025-6196(12)60247-X
Pseudothrombocytopenia: a laboratory artifact with potentially serious consequences.
B. Payne (1984)
10.1097/00007611-198408000-00012
Prognostic factors for splenectomy response in adult idiopathic thrombocytopenic purpura.
Rocco Mv (1984)
10.1001/ARCHINTE.1984.04400020110017
Colchicine therapy for refractory idiopathic thrombocytopenic purpura.
S. Strother (1984)
10.1097/00043426-198424000-00001
Prednisone therapy for children with newly diagnosed idiopathic thrombocytopenic purpura: A randomized clinical trial
G. Buchanan (1984)
10.1016/S0022-3476(85)80231-6
Treatment of acute idiopathic thrombocytopenia of childhood with intravenous infusions of gammaglobulin.
J. Bussel (1985)
10.1016/S0002-9378(85)80254-4
Fetal blood sampling during pregnancy with use of a needle guided by ultrasound: a study of 606 consecutive cases.
F. Daffos (1985)
10.1136/jcp.38.10.1172
Size of spleen rather than amount of platelet sequestration may determine long term responses to splenectomy in adult idiopathic thrombocytopenic purpura.
B. Boughton (1985)
10.1007/BF03029831
Idiopathic thrombocytopenic purpura and pregnancy. Maternal platelet count and antiplatelet antibodies do not predict the risk of neonatal thrombocytopenia
T. Barbui (1985)
10.1148/RADIOLOGY.155.3.4039827
Accessory spleen compromising response to splenectomy for idiopathic thrombocytopenic purpura.
P. Ambriz (1985)
Pregnancy, delivery and detection of antiplatelet antibodies in women with idiopathic thrombocytopenic purpura.
M. G. Mazzucconi (1985)
10.1111/J.1365-2141.1985.TB04070.X
The use of danazol in the management of chronic immune thrombocytopenic purpura
B. Mcverry (1985)
10.1159/000206184
Danazol in idiopathic thrombocytopenic purpura.
D. Almagro (1985)
10.1056/NEJM198606193142501
Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial.
M. H. Gastón (1986)
10.1097/00006254-198711000-00017
Therapeutic effect of danazol on metrorrhagia in patients with idiopathic thrombocytopenic purpura (ITP).
R. Ambriz (1986)
Therapeutic use of colchicine in thrombocytopenia.
Jim Rt (1986)
10.1056/NEJM198608283150916
Thrombocytopenia after treatment with danazol.
J. Arrowsmith (1986)
10.1093/OXFORDJOURNALS.QJMED.A067947
Results of treatment in immune thrombocytopenia.
P. Jacobs (1986)
10.2105/AJPH.76.7.766
Physician ratings of appropriate indications for six medical and surgical procedures.
R. Park (1986)
10.1002/AJH.2830230404
Intravenous gammaglobulin (Gamimune) for treatment of chronic idiopathic thrombocytopenic purpura (ITP): A two‐year follow‐up
I. Warrier (1986)
10.1016/S0140-6736(86)92511-0
FATAL THROMBOTIC EVENTS DURING TREATMENT OF AUTOIMMUNE THROMBOCYTOPENIA WITH INTRAVENOUS IMMUNOGLOBULIN IN ELDERLY PATIENTS
R. Woodruff (1986)
10.1002/AJH.2830210203
Slow infusion of vincristine in the treatment of idiopathic thrombocytopenic purpura
A. Manoharan (1986)
10.1378/CHEST.95.2_SUPPLEMENT.2S
Rules of evidence and clinical recommendations on the use of antithrombotic agents.
D. Sackett (1986)
Therapeutic use of colchicine in thrombocytopenia.
R. T. Jim (1986)
10.1111/J.1445-5994.1986.TB00015.X
Management of splenectomy failures in chronic immune thrombocytopenic purpura: role of accessory splenectomy.
J. Gibson (1986)
Surgical treatment of chronic idiopathic thrombocytopenic purpura: results in 107 cases.
B. Cola (1986)
10.1111/j.1600-0609.1987.tb00756.x
The treatment of adult idiopathic thrombocytopenic purpura
M. Simon (1987)
10.1159/000205948
Danazol therapy in refractory chronic immune thrombocytopenic purpura.
M. G. Mazzucconi (1987)
10.1016/0002-9343(87)90546-8
Comparison of the efficacy of a two-day and a five-day schedule for infusing intravenous gamma globulin in the treatment of immune thrombocytopenic purpura in adults.
R. Kurlander (1987)
10.1016/S0002-9378(87)80074-1
Validity of intrapartum diagnosis of fetal thrombocytopenia.
G. Christiaens (1987)
10.1111/J.1365-2141.1987.TB06878.X
DANAZOL‐INDUCED THROMBOCYTOPENIA
S. Rabinowe (1987)
10.1056/NEJM198702263160903
Effect of danazol in immune thrombocytopenic purpura.
A. Schreiber (1987)
Pregnancy complicated by immune thrombocytopenic purpura.
R. White (1987)
10.1159/000206000
Phase II trial of methylprednisolone pulse therapy in childhood chronic thrombocytopenia.
D. Del Principe (1987)
10.1111/J.1445-5994.1987.TB01276.X
Danazol therapy in patients with immune cytopenias.
A. Manoharan (1987)
Danazol in chronic idiopathic thrombocytopenic purpura resistant to corticosteroids.
S. Kotlarek-Haus (1987)
10.1097/00000658-198710000-00014
Splenectomy for Primary and Recurrent Immune Thrombocytopenic Purpura (ITP): Current Criteria for Patient Selection and Results
O. Akwari (1987)
10.1016/S0022-3476(87)80517-6
Clinical impact of neonatal thrombocytopenia.
M. Andrew (1987)
Splenectomy for idiopathic thrombocytopenic purpura.
Coon Ww (1987)
10.1002/1097-0142(19870901)60:5<1143::AID-CNCR2820600537>3.0.CO;2-E
Pregnancy outcome in cancer patients. Experience in a large cooperative group
J. Mulvihill (1987)
10.1136/bmj.296.6617.249-a
High dose intravenous methylprednisolone or high dose intravenous gammaglobulin for autoimmune thrombocytopenia
A. E. von dem Borne (1988)
10.1136/pgmj.64.752.426
Serious complications following treatment of chronic idiopathic thrombocytopenic purpura.
W. Wanachiwanawin (1988)
10.1016/S0022-3476(88)80705-4
High-dose intravenous gammaglobulin therapy for neonatal autoimmune thrombocytopenia.
A. Ballin (1988)
10.1097/00000441-198807000-00004
Idiopathic thrombocytopenic purpura in the older adult patient.
T. Guthrie (1988)
10.1159/000205627
Slow infusion of vincristine in the treatment of refractory thrombocytopenic purpura.
M. Linares (1988)
10.1111/J.1365-2257.1988.TB00021.X
The treatment of chronic idiopathic thrombocytopenia with anti-D (Rho) immunoglobulin: its effectiveness, safety and mechanism of action.
B. Boughton (1988)
10.3109/00365518809085770
EDTA-dependent pseudothrombocytopaenia: a 12-month epidemiological study.
A. Vicari (1988)
10.1046/j.1537-2995.1988.28188127949.x
Combined plasma exchange and intravenous gammaglobulin in the treatment of patients with refractory immune thrombocytopenic purpura
J. Bussel (1988)
10.1016/0002-9378(88)90414-0
The use of percutaneous umbilical blood sampling in immune thrombocytopenic purpura.
A. Scioscia (1988)
10.1016/0002-9378(88)90582-0
Cordocentesis: an appraisal of risks.
B. Pielet (1988)
10.1177/875647938900500118
Percutaneous Umbilical Cord Blood Sampling in the Evaluation of Fetal Platelet Counts in Pregnant Patients With Autoimmune Thrombocytopenia Purpura
K. Moise (1988)
10.1111/j.1365-2141.1988.tb02492.x
Treatment of idiopathic thrombocytopenic purpura with ascorbate
A. Brox (1988)
10.1182/BLOOD.V72.1.121.BLOODJOURNAL721121
Maintenance treatment of adults with chronic refractory immune thrombocytopenic purpura using repeated intravenous infusions of gammaglobulin.
J. Bussel (1988)
10.1159/000415427
Immune thrombocytopenic purpura and pregnancy.
G. Tchernia (1988)
10.1016/S0022-3476(88)80654-1
Pulse methylprednisolone therapy for acute childhood idiopathic thrombocytopenic purpura.
J. van Hoff (1988)
Danazol therapy for idiopathic thrombocytopenic purpura (ITP).
G. Nalli (1988)
10.1001/ARCHPEDI.1988.02150120071043
Danazol for children with immune thrombocytopenic purpura.
M. Weinblatt (1988)
10.1055/S-0038-1646538
Haemostatic effects of recombinant human erythropoietin in chronic haemodialysis patients.
C. van Geet (1989)
10.1111/J.1445-2197.1989.TB01481.X
Splenectomy for immune thrombocytopenic purpura: Auckland experience 1979-87.
J. Shaw (1989)
10.1002/1097-0142(19891215)64:12<2506::AID-CNCR2820641217>3.0.CO;2-J
Chronic pure thrombocytopenia in elderly patients. An aspect of the myelodysplastic syndrome
Y. Najean (1989)
10.1111/j.1600-0609.1989.tb01466.x
High‐dose intravenous methylprednisolone for acute childhood idiopathic thrombocytopenic purpura
Ş. Özsoylu (1989)
Long-term follow-up of children exposed in utero to antineoplastic agents.
J. Garber (1989)
10.1182/blood.v74.6.1894.bloodjournal7461894
Improvement of platelet counts in steroid-unresponsive idiopathic immune thrombocytopenic purpura after short-course therapy with recombinant alpha 2b interferon.
S. Proctor (1989)
10.1111/j.1365-2141.1989.tb00308.x
INTERFERON ALPHA‐2b THERAPY IN ADULT CHRONIC THROMBOCYTOPENIC PURPURA (ITP)
S. Bellucci (1989)
10.1001/ARCHINTE.1989.00390070157026
Intermittent compression units for the postphlebitic syndrome. A pilot study.
Jeffrey S. Ginsberg (1989)
10.1055/S-0038-1644711
Uremic plasma after infusion of desmopressin (DDAVP) improves the interaction of normal platelets with vessel subendothelium.
G. Escolar (1989)
Unrecognized thrombocytopenia and regional anesthesia in parturients: a retrospective review.
S. Halpern (1989)
10.7326/0003-4819-111-9-723
Long-term danazol therapy in autoimmune thrombocytopenia: unmaintained remission and age-dependent response in women.
Y. Ahn (1989)
10.1159/000205407
Response to splenectomy in idiopathic thrombocytopenic purpura: prognostic value of the clinical and laboratory evaluation.
F. Fabris (1989)
Immune thrombocytopenia purpura: a pilot study of staphylococcal protein A immunomodulation in refractory patients.
T. Guthrie (1989)
10.1111/j.1600-0609.1989.tb00109.x
Reevaluation of the prognostic factors for splenectomy in chronic idiopathic thrombocytopenic purpura (ITP): A report on 181 cases
P. Fenaux (1989)
10.1159/000293654
Management of labor in patients with idiopathic thrombocytopenic purpura.
U. Dan (1989)
Abrupt reversal of gestational autoimmune thrombocytopenia after delivery. A case report.
J. R. Bartholomew (1989)
10.1111/j.1365-2141.1989.tb07674.x
Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival
D. Catovsky (1989)
10.1001/ARCHINTE.1989.00390090039008
Control of bleeding in patients with immune and nonimmune thrombocytopenia with aminocaproic acid.
J. Bartholomew (1989)
10.5555/URI:PII:009377548990002X
Antineoplastic agents and pregnancy.
D. Doll (1989)
Long - term follow - up of children exposed to utero to antieoplastic agents
JE Garber (1989)
Long - term follow - up of children exposed to utero to antieoplastic agents
M Ostensen (1989)
10.1111/j.1365-2141.1990.tb02566.x
Genetic thrombocytopenia with autosomal dominant transmission: a review of 54 cases
Y. Najean (1990)
Infection associated with asplenia: risks, mechanisms, and prevention.
B. Styrt (1990)
10.1111/J.1600-0609.1990.TB00427.X
Danazol therapy in chronic immune thrombocytopenic purpura
A. Flores (1990)
10.1111/j.1365-2141.1990.tb02569.x
Re‐evaluation of the role of azathioprine in the treatment of adult chronic idiopathic thrombocytopenic purpura: a report on 53 cases
I. Quiquandon (1990)
10.1136/pgmj.66.780.827
Danazol in non-splenectomized patients with refractory idiopathic thrombocytopenic purpura.
D. Edelmann (1990)
10.1016/0002-9378(90)90675-W
Low fetal risks in pregnancies associated with idiopathic thrombocytopenic purpura.
R. Burrows (1990)
10.1111/j.1365-2141.1990.tb07814.x
ASCORBATE FOR THE TREATMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA
K. Toyama (1990)
10.1016/0140-6736(90)90701-6
Bleeding in immune thrombocytopenic purpura after alpha-interferon
F. Matthey (1990)
10.1017/S0965539500000334
Immune thrombocytopenia in pregnancy
J. Browning (1990)
10.1001/ARCHINTE.1990.00390200025005
Practice guidelines: a new reality in medicine. I. Recent developments.
S. H. Woolf (1990)
10.1111/j.1365-2141.1990.tb02668.x
TREATMENT OF CHRONIC AUTOIMMUNE THROMBOCYTOPENIC PURPURA WITH ASCORBATE
B. Godeau (1990)
10.1001/ARCHINTE.1990.00390210105023
Pregnancy in women with immune thrombocytopenic purpura.
A. Moutet (1990)
[Low-dose danazol therapy in idiopathic thrombocytopenic purpura].
H. Nozaki (1990)
10.1002/AJH.2830330306
Alternation of two doses of intravenous gammaglobulin in the maintenance treatment of patients with immune thrombocytopenic purpura: More is not always better
J. Bussel (1990)
10.1111/j.1365-2141.1990.tb07880.x
Lack of useful clinical predictors of response to splenectomy in patients with chronic idiopathic thrombocytopenic purpura
A. Julià (1990)
10.1016/0140-6736(90)92924-7
Fetal platelet counts in thrombocytopenic pregnancy
J. Copplestone (1990)
10.1001/jama.1990.03440090103036
Practice policies: where do they come from?
D. Eddy (1990)
10.1093/tropej/36.1.10
Childhood idiopathic thrombocytopenic purpura: report of 60 cases from Kuwait.
M. Zaki (1990)
10.1111/j.1365-2141.1990.00156.x-i1
ASCORBATE FOR THE TREATMENT OF REFRACTORY IDIOPATHIC THKOMBOCYTOPENIC PIJRPURA
C. E. G. Verhoef (1990)
10.1136/adc.65.5.502
Idiopathic thrombocytopenic purpura: predictors of chronic disease.
L. Robb (1990)
10.1111/J.1365-2141.1990.TB07816.X
ASCORBATE FOR THE TREATMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA
K. Ghosh (1990)
10.1182/BLOOD.V77.9.1884.1884
Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of effect.
J. Bussel (1991)
10.1111/j.1445-5994.1991.tb01339.x
Targeted‐immunosuppression with vincristine infusion in the treatment of immune thrombocytopenia
A. Manoharan (1991)
10.1016/0277-5379(91)90577-Z
alpha Interferon therapy in the treatment of idiopathic thrombocytopenic purpura.
S. Proctor (1991)
10.1016/0140-6736(91)92098-M
Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia
J. Gmur (1991)
10.1016/0140-6736(91)91762-J
Long-term response of immune thrombocytopenia to extracorporeal immunoadsorption
J. Balint (1991)
10.1111/j.1471-0528.1991.tb13527.x
Idiopathic thrombocytopenic purpura in pregnancy; A randomized trial on the effect of antenatal low dose corticosteroids on neonatal platelet count
P. Owen (1991)
10.1097/00006254-199102000-00006
Estimation of the Risk of Thrombocytopenia in the Offspring of Pregnant Women with Presumed Immune Thrombocytopenic Purpura
P. Samuels (1991)
Pulmonary and renal toxicity of intravenous immunoglobulin.
R. Rault (1991)
10.1016/0020-7292(91)90557-L
Thrombocytopenia at delivery: A prospective survey of 6715 deliveries
R. Burrows (1991)
10.1182/BLOOD.V77.1.31.31
High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura.
S. Cortelazzo (1991)
Immune Thrombocytopenic Purpura in Pregnancy: A Reappraisal of Management
R. Cook (1991)
A Manuel for Assessing Health Practices and Designing Practice Guidelines: The Explicit Approach
DM Eddy (1991)
Long - term response of immune thrombocytopenia to extracorporeal immu - noadsorption
HW Snyder (1991)
10.1111/J.1600-0609.1992.TB01797.X
Ascorbate for the treatment of ITP
J.W. Beek‐Boter (1992)
10.1002/AJH.2830410308
Accessory spleen in recurrent chronic immune thrombocytopenic purpura
T. Facon (1992)
10.1002/AJH.2830390215
Letter to the editor: EDTA‐dependent pseudothrombocytopenia in ambulatory patients: Clinical characteristics and role of new automated cell‐counting in its detection
J. Garcia Suarez (1992)
10.1111/J.1600-0609.1992.TB01806.X
Recombinant alpha‐2b interferon in refractorv idiopathic immune thrombocytopenia
P. Iannaccaro (1992)
10.1111/j.1600-0897.1992.tb00776.x
Glucocorticoid Therapy for Rheumatic Diseases: Maternal, Fetal, and Breast‐Feeding Considerations
W. Rayburn (1992)
10.7326/0003-4819-116-12-977
Splenic radiation for corticosteroid-resistant immune thrombocytopenia.
D. Calverley (1992)
10.1111/j.1600-0897.1992.tb00778.x
Treatment With Immunosuppressive and Disease Modifying Drugs During Pregnancy and Lactation
M. Ostensen (1992)
10.1182/blood.v79.9.2237.bloodjournal7992237
Experience with protein A-immunoadsorption in treatment-resistant adult immune thrombocytopenic purpura.
H. W. Snyder (1992)
10.1111/J.1365-2141.1992.TB06483.X
FURTHER CONCERN OVER USE OF ALPHA‐INTERFERON IN IMMUNE THROMBOCYTOPENIC PURPURA
J. Hudson (1992)
Treatment of refractory immune thrombocytopenic purpura with ascorbate.
N. Novitzky (1992)
Institute of Medicine Committee on Clinical Practice Guidelines
M. Field (1992)
Guidelines for Clinical Practice: From Development to Use
M. Field (1992)
10.1016/S0022-3476(10)80001-0
A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D.
M. Andrew (1992)
10.1182/BLOOD.V80.11.2697.BLOODJOURNAL80112697
Pregnancy-associated thrombocytopenia: pathogenesis and management.
K. McCrae (1992)
10.1001/ARCHINTE.1992.00400170036007
Practice guidelines, a new reality in medicine. II. Methods of developing guidelines.
S. Woolf (1992)
A follow-up study of 49 adult patients with idiopathic thrombocytopenic purpura treated with high-dose immunoglobulins and anti-D immunoglobulins.
F. Rodeghiero (1992)
Diagnosis and management of thrombocytopenia in obstetric syndromes
PJ Ballem (1992)
10.1002/AJH.2830430110
Pilot study of ascorbic acid for the treatment of refractory immune thrombocytopenic purpura.
J. Sj (1993)
Acute renal failure after high-dose intravenous immune globulin in a patient with idiopathic thrombocytopenic purpura.
M. Ruggeri (1993)
10.1182/BLOOD.V82.12.3789.BLOODJOURNAL82123789
Hemolysis after high-dose intravenous Ig [letter]
M. Thomas (1993)
10.1182/BLOOD.V81.12.3484.3484
2-Chlorodeoxyadenosine in the treatment of chronic refractory immune thrombocytopenic purpura [letter]
M. Figueroa (1993)
10.1182/BLOOD.V82.9.2714.2714
Acute Thrombocytopenic Purpura in Relation to the Use of Drugs
D. Kaufman (1993)
10.1159/000204523
Results of Splenectomy for Idiopathic Thrombocytopenic Purpura
A. Naouri (1993)
Results of splenectomy for idiopathic thrombocytopenic purpura. Review of 72 cases.
A. Naouri (1993)
10.1001/ARCHSURG.1993.01420170101015
Portal vein thrombosis after elective splenectomy. An underappreciated, potentially lethal syndrome.
D. Rattner (1993)
10.1056/NEJM199304293281703
Combination chemotherapy in refractory immune thrombocytopenic purpura.
M. Figueroa (1993)
10.1016/S0022-3476(05)80400-7
A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura.
V. Blanchette (1993)
10.7326/0003-4819-119-10-199311150-00001
Low-Dose Prednisone Induces Rapid Reversible Axial Bone Loss in Patients with Rheumatoid Arthritis
R. Laan (1993)
10.1001/ARCHNEUR.1993.00540020015010
Acute renal failure resulting from intravenous immunoglobulin therapy.
E. Tan (1993)
10.1182/blood.v81.12.3484.bloodjournal81123484
2-Chlorodeoxyadenosine in the treatment of chronic refractory immune thrombocytopenic purpura.
M. Figueroa (1993)
10.1182/BLOOD.V82.5.1415.BLOODJOURNAL8251415
Treatment of adult chronic autoimmune thrombocytopenic purpura with repeated high-dose intravenous immunoglobulin.
B. Godeau (1993)
10.1002/AJH.2830430403
α‐interferon therapy for severe chronic idiopathic thrombocytopenic purpura in children
Richard J. Cohn (1993)
10.1182/BLOOD.V81.3.828.828
Human immunodeficiency virus-related conditions in children and adults with hemophilia: rates, relationship to CD4 counts, and predictive value.
Eyster Me (1993)
10.1159/000204392
Idiopathic thrombocytopenic purpura in Egyptian children.
A. Khalifa (1993)
10.1097/00006254-199312000-00003
Pregnancy in Patients With Idiopathic Thrombocytopenic Purpura: Assessing the Risks for the Infant at Delivery
R. Burrows (1993)
10.1002/ajh.2830430110
Pilot study of ascorbic acid for the treatment of refractory immune thrombocytopenic purpura
S. Jubelirer (1993)
10.1001/JAMA.270.21.2598
Users' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-Based Medicine Working Group.
G. Guyatt (1993)
10.1001/ARCHINTE.1993.00410230060008
Practice guidelines: a new reality in medicine. III. Impact on patient care.
S. Woolf (1993)
Platelets and pregnancy . Chapter 4
RF Burrows (1993)
10.1016/S0140-6736(94)90843-5
Severe adverse effects of protein A immunoadsorption
A. Käbisch (1994)
10.1182/BLOOD.V84.12.4203.BLOODJOURNAL84124203
Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpura.
R. Stasi (1994)
10.1148/RADIOLOGY.190.1.8259430
Splenic vein thrombosis after splenectomy: frequency and role of imaging.
P. Petit (1994)
10.1056/NEJM199412153312402
Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin.
K. Bjøro (1994)
10.1016/0002-9343(94)90048-5
Intravenous gammaglobulin has no advantages over oral corticosteroids as primary therapy for adults with immune thrombocytopenia: a prospective randomized clinical trial.
P. Jacobs (1994)
High-titer antinuclear antibodies, anti-SSA/Ro antibodies and anti-nuclear RNP antibodies in patients with idiopathic thrombocytopenic purpura.
Y. Kurata (1994)
10.1002/AJH.2830460206
Low fetal morbidity in pregnancy associated with acute and chronic idiopathic thrombocytopenic purpura
Rivka Sharon (1994)
10.1111/j.1365-2141.1994.tb04810.x
A randomized trial comparing vinblastine in slow infusion and by bolus i.v. injection in idiopathic thrombocytopenic purpura: a report on 42 patients
T. Façon (1994)
Side-effects of intravenous immune globulins.
C. Duhem (1994)
10.1016/S0022-3476(05)82024-4
Acute immune thrombocytopenic purpura: a comparative study of very high oral doses of methylprednisolone and intravenously administered immune globulin.
D. Albayrak (1994)
10.1002/AJH.2830460212
Mortality in immune thrombocytopenic purpura: Report of seven cases and consideration of prognostic indicators
E. Schattner (1994)
10.1055/S-2007-994534
Accurate intrapartum estimation of fetal platelet count by fetal scalp samples smear.
D. Adams (1994)
10.1097/00006254-199404000-00009
Fetal Thrombocytopenia and Its Relation to Maternal Thrombocytopenia
R. Burrows (1994)
10.1111/J.1365-2141.1994.TB05083.X
Treatment of chronic childhood immune thrombocytopenic purpura with intramuscular anti‐D immunoglobulins
C. Borgna-Pignatti (1994)
10.1111/J.1600-0609.1994.TB00651.X
Interferon treatment of refractory idiopathic thrombocytopenic purpura (ITP)
P. Dubbeld (1994)
10.2214/AJR.163.1.8010197
Partial splenic embolization for the treatment of chronic idiopathic thrombocytopenic purpura.
M. Miyazaki (1994)
10.1212/WNL.44.2.223
High‐dose intravenous immunoglobulin and serum viscosity
M. Dalakas (1994)
Case records of the Massachusetts General Hospital . A 55 - year - old woman with a skin rash and hemiparesis after staphylococcal protein A column therapy
WH Dzik (1994)
10.1016/S0140-6736(95)91002-6
Hepatitis C transmission associated with intravenous immunoglobulins
M. Yu (1995)
10.1136/adc.72.2.125
Chronic idiopathic thrombocytopenic purpura: incidence, treatment, and outcome.
M. Reid (1995)
10.7326/0003-4819-122-10-199505150-00022
Possible Transmission of Hepatitis C Virus Infection with Intravenous Immunoglobulin
T. Schiano (1995)
10.1111/j.1365-2141.1995.tb05231.x
THROMBOCYTOPENIC PURPURA FOLLOWING TREATMENT WITH DANAZOL
F. Laveder (1995)
10.1002/AJH.2830480408
Reliability of automated platelet counts: Comparison with manual method and utility for prediction of clinical bleeding
J. Lawrence (1995)
10.1002/PD.1970150506
The role of percutaneous umbilical blood sampling in the management of immune thrombocytopenic purpura
S. Garmel (1995)
10.1002/AJH.2830480207
Characterization of autoantibodies against the platelet glycoprotein antigens llb/llla in childhood idiopathic thrombocytopenia purpura
J. Taub (1995)
10.1016/0002-9378(95)90559-6
Alloimmune thrombocytopenia: fetal and neonatal losses related to cordocentesis.
M. Paidas (1995)
How to Use an Article About Therapy or Prevention
G. Guyatt (1995)
10.1111/j.1365-2141.1995.tb05271.x
Splenic irradiation for chronic autoimmune thrombocytopenic purpura in patients with contra‐indications to splenectomy
M. Caulier (1995)
10.7326/0003-4819-122-3-199502010-00005
Estimating the Risk for Sepsis after Splenectomy in Hereditary Spherocytosis
R. Schilling (1995)
10.1182/BLOOD.V85.2.351.351
Pulse cyclophosphamide therapy for refractory autoimmune thrombocytopenic purpura.
A. Reiner (1995)
Thrombocytopenia due to enhanced platelet destruction by immunologic mechanisms
JN George (1995)
Experience with protein A - immunoad - sorption in treatment - resistant adult immune thrombocytopenic purpura
HW Snyder
Acces - sory splenectomy in management of recurrent idiopathic thrombocytopenic purpura
CN Verheyden



This paper is referenced by
10.21037/aob-20-87
Efficacy and mechanism of intravenous immunoglobulin treatment for immune thrombocytopenia in adults
Ruqayyah J Almizraq (2021)
10.1111/bjh.17390
Thrombosis in immune thrombocytopenia — current status and future perspectives
Dawn Swan (2021)
10.1007/978-981-16-1216-9_3
Pathology and Pathophysiology of Surgical Spleen Diseases
He Cai (2021)
10.32708/UUTFD.835838
Primer-Kronik İdiyopatik Trombositopenik Purpuralı tanılı hastalarda splenektominin uzun dönem sonuçları: 300 hastadan oluşan tek merkez deneyimi
Yüksel Altınel (2021)
10.1136/bcr-2021-241985
Challenges of left atrial appendage closure device and anticoagulation in a patient with immune thrombocytopenia (ITP)
M. Uddin (2021)
10.1007/s42979-021-00458-2
Red Blood Cell Classification Using Image Processing and CNN
M. Parab (2021)
Immune Thrombocytopenic Purpura in Review
M. Hussein (2021)
10.1080/17512433.2021.1903315
Update on diagnosis and treatment of immune thrombocytopenia
R. Sandal (2021)
10.5505/EJM.2021.34735
Outcomes Of Splenectomy For Hematologic Diseases - A Single Center Experience
I. Çalli (2021)
10.1111/ajo.13303
HOW Collaborative position paper on the management of thrombocytopenia in pregnancy
R. Eslick (2021)
10.1002/ajh.25989
High‐dose dexamethasone plus recombinant human thrombopoietin vs high‐dose dexamethasone alone as frontline treatment for newly diagnosed adult primary immune thrombocytopenia: A prospective, multicenter, randomized trial
Yafei Yu (2020)
10.3390/microorganisms8101457
Efficacy of Helicobacter pylori Eradication Therapy on Platelet Recovery in Pediatric Immune Thrombocytopenic Purpura-Case Series and a Systematic Review
Tamaki Ikuse (2020)
10.1007/978-3-642-54671-6_220-2
Hämorrhagische Diathesen bei Kindern und Jugendlichen
F. Bergmann (2020)
10.1016/j.revmed.2020.06.018
Traitements de première ligne au cours du purpura thrombopénique immunologique de l'adulte : état des lieux et perspectives
B. Godeau (2020)
10.1080/17474086.2020.1711729
Management of immune thrombocytopenia in women: current standards and special considerations
F. Rodeghiero (2020)
10.1101/2020.05.16.087239
Red blood cell classification using image processing and CNN
M. Parab (2020)
10.1055/A-0865-4442
5 Yearsʼ Experience of a Tertiary Center with Thrombocytopenic Pregnancies: Gestational Thrombocytopenia, Idiopathic Thrombocytopenic Purpura and Hypertensive Disorders of Pregnancy
Erdem Fadiloğlu (2020)
10.1182/bloodadvances.2020003074
A risk score for predicting hospitalization for community-acquired pneumonia in ITP using nationally representative data.
Ye-Jun Wu (2020)
10.1186/s41182-020-00248-1
Dengue hemorrhagic fever as a rare cause of chronic immune thrombocytopenic purpura—a pediatric case report
V. Thadchanamoorthy (2020)
10.1007/s11239-020-02083-x
Risk Of Thrombosis In Elderly Immune Primary Trombocytopenic Patients Treated with Thrombopoietin Receptors Agonists
R. Castelli (2020)
10.1016/b978-0-7020-6956-7.00041-5
Fetal Platelet Disorders
D. Winkelhorst (2020)
10.21037/ALES-19-260
Idiopathic thrombocytopenic purpura: current therapeutical strategies and review of the literature on outcome after splenectomy
R. Vecchio (2020)
10.1186/s13075-020-02183-2
A unique thymus-derived regulatory T cell subset associated with systemic lupus erythematosus
H. Hanaoka (2020)
10.3324/haematol.2020.261099
Splenectomy for immune thrombocytopenia: the evolution and preservation of treatment
Allison S Remiker (2020)
10.1080/09537104.2020.1751105
Report of a ‘consensus’ on the lines of therapy for primary immune thrombocytopenia in adults, promoted by the Italian Gruppo di Studio delle Piastrine
L. Cirasino (2020)
10.4103/ejs.ejs_170_19
Laparoscopic splenectomy: Assiut University early experience
M. Aly (2020)
10.1007/s12185-019-02790-z
Reference guide for management of adult immune thrombocytopenia in Japan: 2019 Revision
H. Kashiwagi (2020)
10.2174/1389200221666200413125011
Aox1 And Xdh Enzymes Genotyping And Its Effect On Clinical Response To Azathioprine In Inflammatory Bowel Disease Patients Among Jordanian Population.
S. Mahasneh (2020)
Comparative study of perinatal outcome in pregnant patients with thrombocytopenia and those with normal platelet count
Dr Rinku (2020)
10.14302/issn.2372-6601.jhor-20-3372
Laboratory Tests Used in the Diagnosis of Immune Thrombocytopenia and General Treatment Approaches
F. Ozcelik (2020)
Evaluation of eradication therapy for Helicobacter pylori on platelet counts of Patients with Immune thrombocytopenic purpura (ITP)
R. Aghabozorgi (2019)
10.5546/aap.2019.S243
[Guideline for diagnosis and treatment of immune thrombocytopenia].
H. Donato (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar